Results 191 to 200 of about 278,683,873 (354)
Hybrid communication systems, FSO/RF and RoF : reliable and scaled communications anywhere [PDF]
Perez Soler, Joaquin
core
Cell‐free DNA aneuploidy score as a dynamic early response marker in prostate cancer
mFast‐SeqS‐based genome‐wide aneuploidy scores are concordant with aneuploidy scores obtained by whole genome sequencing from tumor tissue and can predict response to ARSI treatment at baseline and, at an early time point, to ARSI and taxanes. This assay can be easily performed at low cost and requires little input of cfDNA. Cell‐free circulating tumor
Khrystany T. Isebia+17 more
wiley +1 more source
Thermal Desorption and Extraction Coupled With Gas Chromatography and Mass Spectrometry for the Quantification of Polystyrene Nanoplastic in Pak Choi. [PDF]
Zytowski E, Baldermann S.
europepmc +1 more source
Butorphanol-induced pruritus antagonized by naloxone
Joel E. Bernstein, Richard A. Grinzi
openalex +1 more source
The Opiate Antagonist Naloxone Counteracts the Inhibition of Sympathetic Nerve Activity Caused by Halothane Anesthesia in Rats [PDF]
Martin Delle+2 more
openalex +1 more source
Prostate cancer is a leading malignancy with significant clinical heterogeneity in men. An 11‐gene signature derived from dysregulated epithelial cell markers effectively predicted biochemical recurrence‐free survival in patients who underwent radical surgery or radiotherapy.
Zhuofan Mou, Lorna W. Harries
wiley +1 more source
Adult-onset Bartter syndrome type IV B with ACTH secreting pituitary microadenoma. [PDF]
Mathew GG.
europepmc +1 more source
Clinical significance of stratifying prostate cancer patients through specific circulating genes
We tested a specific panel of genes representative of luminal, neuroendocrine and stem‐like cells in the blood of prostate cancer patients, showing predictive value from diagnosis to late stages of disease. This approach allows monitoring of treatment responses and outcomes at specific time points in trajectories.
Seta Derderian+12 more
wiley +1 more source